Tissue Factor Pathway Inhibitor in Pediatric Patients with Nephrotic Syndrome
Rania Saleh Beltagi;
Abstract
Background: Tissue factor pathway inhibitor (TFPI) is the major down regulator of the procoagulant activity of the TF/ FVIIa complex. The mature TFPI protein, previously known as lipoprotein-associated coagulation inhibitor (LACI) or extrinsic pathway inh
Other data
| Title | Tissue Factor Pathway Inhibitor in Pediatric Patients with Nephrotic Syndrome | Other Titles | مثبط مسار العامل النسيجي في الأطفال المصابين بالاوديما الكلوية | Authors | Rania Saleh Beltagi | Keywords | Tissue Factor Pathway Inhibitor in Pediatric Patients with Nephrotic Syndrome | Issue Date | 2010 | Description | Background: Tissue factor pathway inhibitor (TFPI) is the major down regulator of the procoagulant activity of the TF/ FVIIa complex. The mature TFPI protein, previously known as lipoprotein-associated coagulation inhibitor (LACI) or extrinsic pathway inh |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.